NCT01755468View on ClinicalTrials.gov

Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Type 2 Diabetes
Interventions
DRUG

Intermittent insulin therapy

DRUG

Continuous metformin

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Mount Sinai Hospital, Canada

OTHER

NCT01755468 - Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study) | Biotech Hunter | Biotech Hunter